← Back to Knowledge Base

Primary topic: inflammation immune signaling pathway

Inflammation and Immune Signaling Pathway: Why Low-Grade Pressure Changes the Whole Picture

This pathway matters when recovery, histamine, fatigue, or redox issues all seem to worsen under the same inflammatory load.

What this pathway does

The pathway coordinates inflammatory signaling, downstream acute-phase response, and the broader immune tone that shapes recovery and symptom intensity.

Why it matters

It matters because inflammation changes how many other pathways behave, including histamine, oxidative stress, and iron handling.

What creates pressure on this pathway

  • stronger inflammatory signaling under immune or environmental load
  • more spillover into ferritin, histamine, or redox interpretation

Validation markers to consider

  • hsCRP
  • ferritin context
  • CBC and broader inflammatory context

Genes and SNPs connected to this pathway

Inflammation is your immune system's alarm response. It helps fight threats, but too much or too often can make you feel worse.

Study rows support the SNP/gene claim. The pathway connection comes from the curated gene-to-pathway map.

What may run higher

Your immune alarm may turn on too easily or stay on too long.

What may work more slowly

Your immune alarm may be slower or weaker.

What to check next

Check hs-CRP, CBC with differential, ferritin context, fasting glucose, HbA1c, lipid markers, sleep, infection, and injury history.

11mapped genes
13mapped SNPs
17SNP/gene claims
15report eligible
CRP2 SNPs - 4 claimsShow SNPsOpen gene page
rs12053 claims - 9 study rows

biomarker tendency - TT

CRP biomarker tendency

Strong

rs1205 TT is associated with reduced CRP biomarker tendency.

CRP rs1205 is scored as a lower circulating C-reactive-protein biomarker tendency for T-containing genotypes, strongest for TT and intermediate for CT.

Likely effectLower biomarker tendency
Signal sizeSmall signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence

biomarker tendency - CT

CRP biomarker tendency

Moderate

rs1205 CT is associated with reduced CRP biomarker tendency.

CRP rs1205 is scored as a lower circulating C-reactive-protein biomarker tendency for T-containing genotypes, strongest for TT and intermediate for CT.

Likely effectLower biomarker tendency
Signal sizeSmall signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence

biomarker tendency - CC

CRP biomarker tendency

Not used for pathway scoring

rs1205 CC has no scored directional claim for CRP biomarker tendency.

CRP rs1205 is scored as a lower circulating C-reactive-protein biomarker tendency for T-containing genotypes, strongest for TT and intermediate for CT.

Likely effectNo clear biomarker tendency
Signal sizeMinimal signal
Evidence supportVery limited support
Report useEvidence only, not scored
Show study evidence
rs18009471 claims - 2 study rows

biomarker tendency - C

serum C-reactive protein biomarker tendency

Moderate

rs1800947 C in CRP is associated with lower circulating C-reactive protein tendency.

CRP rs1800947 C is staged as a lower serum CRP biomarker allele.

Likely effectLower biomarker tendency
Signal sizeSmall signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence
NFKB11 SNPs - 3 claimsShow SNPsOpen gene page
rs46480683 claims - 6 study rows

expression - GG

NFKB1 gene expression

Strong

rs4648068 GG is associated with increased NFKB1 gene expression.

NFKB1 rs4648068 is scored as a higher NFKB1 expression tendency for G-containing genotypes, strongest for GG and intermediate for AG.

Likely effectHigher gene expression signal
Signal sizeModerate signal
Evidence supportModerate support
Report useIncluded in pathway scoring
Show study evidence

expression - AG

NFKB1 gene expression

Moderate

rs4648068 AG is associated with increased NFKB1 gene expression.

NFKB1 rs4648068 is scored as a higher NFKB1 expression tendency for G-containing genotypes, strongest for GG and intermediate for AG.

Likely effectHigher gene expression signal
Signal sizeSmall signal
Evidence supportModerate support
Report useIncluded in pathway scoring
Show study evidence

expression - AA

NFKB1 gene expression

Not used for pathway scoring

rs4648068 AA has no scored directional claim for NFKB1 gene expression.

NFKB1 rs4648068 is scored as a higher NFKB1 expression tendency for G-containing genotypes, strongest for GG and intermediate for AG.

Likely effectNo clear expression signal
Signal sizeMinimal signal
Evidence supportVery limited support
Report useEvidence only, not scored
Show study evidence
NLRP32 SNPs - 2 claimsShow SNPsOpen gene page
rs107545581 claims - 2 study rows

biomarker tendency - G

IL-1 beta inflammasome biomarker tendency

Moderate

rs10754558 G at NLRP3 is associated with higher IL-1 beta inflammatory biomarker tendency in inflammatory disease cohorts.

NLRP3 rs10754558 G is staged as a higher IL-1 beta inflammasome biomarker tendency; generalized higher NLRP3 expression is not asserted.

Likely effectHigher biomarker tendency
Signal sizeSmall signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence
rs358294191 claims - 1 study rows

biomarker tendency - A

NLRP3 inflammasome cytokine tendency

Moderate

rs35829419 A / NLRP3 Gln705Lys is associated with higher NLRP3 inflammasome IL-1 beta and IL-18 production tendency in stimulated-cell context.

NLRP3 rs35829419 A is staged as a low-penetrance gain-of-function inflammasome cytokine tendency allele.

Likely effectHigher biomarker tendency
Signal sizeSmall signal
Evidence supportModerate support
Report useIncluded in pathway scoring
Show study evidence
FOXO31 SNPs - 1 claimsShow SNPsOpen gene page
rs122120671 claims - 2 study rows

biomarker tendency - G

monocyte inflammatory cytokine response tendency

Moderate

rs12212067 G is associated with lower stimulated monocyte pro-inflammatory cytokine response tendency.

FOXO3 rs12212067 G is staged as lower monocyte TNF-alpha / IL-1 beta / IL-6 / IL-8 response and higher IL-10 tendency under inflammatory stimulation.

Likely effectLower biomarker tendency
Signal sizeSmall signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence
IL1RN1 SNPs - 1 claimsShow SNPsOpen gene page
rs42519611 claims - 1 study rows

biomarker tendency - C

IL-1 receptor antagonist buffering tendency

Moderate

rs4251961 C is associated with lower IL-1 receptor antagonist production and higher systemic inflammatory-marker tendency.

IL1RN rs4251961 C is staged as reduced IL-1RA buffering, which can increase IL-1 inflammatory tone.

Likely effectLower biomarker tendency
Signal sizeSmall signal
Evidence supportModerate support
Report useIncluded in pathway scoring
Show study evidence
IL6R1 SNPs - 1 claimsShow SNPsOpen gene page
rs22281451 claims - 2 study rows

biomarker tendency - C

classical IL-6 receptor signaling tendency

Strong

rs2228145 C / Ala358 is associated with lower membrane IL-6R classical signaling tendency and higher soluble IL-6R.

IL6R rs2228145 C is staged for reduced membrane/classical IL-6R signaling, not as a generic lower-inflammation claim.

Likely effectLower biomarker tendency
Signal sizeSmall signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence
KLKB11 SNPs - 1 claimsShow SNPsOpen gene page
rs1219649521 claims - 2 study rows

enzyme activity - AA or compound-heterozygous KLKB1 deficiency context

Plasma prekallikrein activity tendency

Strong

rs121964952 A / KLKB1 c.367G>A / p.Gly123Arg is associated with lower plasma prekallikrein activity in recessive or compound-heterozygous prekallikrein deficiency contexts.

KLKB1 rs121964952 A is staged as a plasma prekallikrein deficiency allele affecting contact-system protease activation and kinin biology.

Likely effectLower enzyme activity signal
Signal sizeModerate signal
Evidence supportModerate support
Report useIncluded in pathway scoring
Show study evidence
MBL21 SNPs - 1 claimsShow SNPsOpen gene page
rs18004501 claims - 2 study rows

biomarker tendency - A

serum mannose-binding lectin tendency

Strong

rs1800450 A / MBL2 codon 54 B allele is associated with lower serum mannose-binding lectin tendency.

MBL2 rs1800450 A is staged as a lower circulating MBL protein and lectin-complement support allele.

Likely effectLower biomarker tendency
Signal sizeModerate signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence
P2RX71 SNPs - 1 claimsShow SNPsOpen gene page
rs37511431 claims - 2 study rows

enzyme activity - C

P2X7 ATP receptor signaling tendency

Strong

rs3751143 C / P2RX7 Ala496 is associated with lower P2X7 ATP-gated receptor signaling tendency.

P2RX7 rs3751143 C is staged as a loss-of-function inflammatory receptor-signaling allele.

Likely effectLower enzyme activity signal
Signal sizeModerate signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence
SERPING11 SNPs - 1 claimsShow SNPsOpen gene page
rs289408701 claims - 2 study rows

enzyme activity - T / p.Arg466Cys in heterozygous SERPING1 deficiency context

C1 inhibitor contact-system activity tendency

Strong

rs28940870 T / SERPING1 c.1396C>T / p.Arg466Cys is associated with lower functional C1 inhibitor control of complement and contact-system proteases in hereditary angioedema contexts.

SERPING1 rs28940870 T is staged as a pathogenic reactive-site allele affecting C1 inhibitor function, complement C4 context, and bradykinin/contact-system inflammatory regulation.

Likely effectLower enzyme activity signal
Signal sizeModerate signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence
TLR11 SNPs - 1 claimsShow SNPsOpen gene page
rs57436181 claims - 2 study rows

expression - GG

TLR1 surface trafficking tendency

Strong

rs5743618 GG / 602S/S is associated with lower TLR1 surface trafficking and lower soluble TLR1/2 agonist response.

TLR1 rs5743618 G is staged as a recessive surface-trafficking and soluble agonist-response variant.

Likely effectLower gene expression signal
Signal sizeModerate signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence

Where DNA analysis helps

DNA helps decide whether inflammation belongs in the main follow-up layer instead of being treated as a vague background concept.

Example interpretation

Inflammation may deserve separate follow-up when immune-tone genes align with symptom and biomarker context.

Suggested validation: hsCRP plus ferritin context.

What to do next

  • validate hsCRP before over-reading immune genetics
  • compare inflammatory genes with histamine and oxidative-stress signals as one cluster

Related pages